This is the authors' abstract. We don't add key points for this paper.
the RI is highly frequent in cancer patients. In all, 80% of the patients receive potentially nephrotoxic drugs and/or for which dosage must be adjusted in RI. Oncologists should check the appropriate dose of chemotherapeutic drugs in relation to renal function before prescribing.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Janus et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: